Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine

被引：44

作者：

Koong, Lin Ru ^{[1
]}

Chee, Wai Kitt ^{[1
]}

Toh, Zhi Hong ^{[1
]}

Ng, Xin Le ^{[1
]}

Agrawal, Rupesh ^{[1
,2
,3
,4
]}

Ho, Su Ling ^{[1
]}

机构：

[1] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore 308433, Singapore

[2] Lee Kong Chian Sch Med, Singapore, Singapore

[3] Singapore Eye Res Inst, Ocular Infect & AntiMicrobials, Singapore, Singapore

[4] Duke NUS Med Sch, Acad & Clin Programme, Ophthalmol & Visual Sci, Singapore, Singapore

来源：

OCULAR IMMUNOLOGY AND INFLAMMATION | 2021年 / 29卷 / 06期

关键词：

COVID-19; vaccine; VKH disease; PfizerBioNtech; vaccine side effects; exudative retinal detachment;

D O I：

10.1080/09273948.2021.1974492

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

A 54-year-old Chinese male with no previous ocular history presented to the ophthalmology department for the bilateral acute painless blurring of vision after receiving the 1st dose of COVID-19 mRNA vaccine (PFIZER-BioNTech/COMIRNATY). Clinical examination and imaging tests were consistent with Vogt-Koyanagi-Hara disease. The patient responded well with a high dose of intravenous methylprednisolone followed by a tapering dose of oral prednisolone.

引用

页码：1212 / 1215

页数：4